LD710Introduced in the House
An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications
Introduced by Samuel Zager, District 116
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications
Where it stands
PASSED TO BE ENACTED, in concurrence.
May 27, 2025
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
Received by the Clerk of the House on February 20, 2025.
The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 401.
Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.
Work Session Held
Voted: OTP-AM
Reported Out: OTP-AM
CONSENT CALENDAR - FIRST DAY
Under suspension of the rules CONSENT CALENDAR - SECOND DAY.
The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-207).
Sent for concurrence. ORDERED SENT FORTHWITH.
Report READ and ACCEPTED, in concurrence.
READ ONCE.
Committee Amendment "A" (H-207) READ and ADOPTED, in concurrence.
Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (H-207), in concurrence.
Ordered sent down forthwith.
PASSED TO BE ENACTED.
Sent for concurrence. ORDERED SENT FORTHWITH.
PASSED TO BE ENACTED, in concurrence.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.